LAB
STANDARD BIOTOOLS INC.
Key Financials
Operating Income
$-110249000
↑ 37.1%
Net Income
$-74896000
↑ 46.1%
EPS (Diluted)
$-0.20
↑ 61.5%
Revenue
$85.3M
↓ 51.1%
Gross Profit
$42.5M
↓ 49.5%
Total Assets
$567.8M
↓ 7.3%
Shareholders' Equity
$424.3M
↓ 10.1%
Total Liabilities
$143.5M
↑ 2.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D | 6/12/2026 | View on SEC |
| SCHEDULE 13D/A | 6/9/2026 | View on SEC |
| 425 | 6/8/2026 | View on SEC |
| 8-K | 6/8/2026 | View on SEC |
| 8-K | 6/5/2026 | View on SEC |
| 8-K | 6/3/2026 | View on SEC |
| SD | 5/29/2026 | View on SEC |
| 8-K | 5/28/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LAB |
| Company Name | STANDARD BIOTOOLS INC. |
| CIK | 1162194 |
| Sector | Laboratory Analytical Instruments |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6502666000 |